Nanoemulsions : The rising star of antiviral therapeutics and nanodelivery system-current status and prospects

© 2021 Elsevier Ltd. All rights reserved..

Nanoemulsions (NEs) of essential oil (EO) have significant potential to target microorganisms, especially viruses. They act as a vehicle for delivering antiviral drugs and vaccines. Narrowing of drug discovery pipeline and the emergence of new viral diseases, especially, coronavirus disease, have created a niche to use NEs for augmenting currently available therapeutic options. Published literature demonstrated that EOs have an inherent broad spectrum of activity across bacterial, fungal, and viral pathogens. The emulsification process significantly improved the efficacy of the active ingredients in the EOs. This article highlights the research findings and patent developments in the last 2 years especially, in EO antiviral activity, antiviral drug delivery, vaccine delivery, viral resistance development, and repurposing EO compounds against SARS-CoV-2.

Medienart:

E-Artikel

Erscheinungsjahr:

2021

Erschienen:

2021

Enthalten in:

Zur Gesamtaufnahme - volume:54

Enthalten in:

Current opinion in colloid & interface science - 54(2021) vom: 30. Aug., Seite 101458

Sprache:

Englisch

Beteiligte Personen:

Franklyne, Jonathan Sampath [VerfasserIn]
Gopinath, Ponnusamy Manogaran [VerfasserIn]
Mukherjee, Amitava [VerfasserIn]
Chandrasekaran, Natarajan [VerfasserIn]

Links:

Volltext

Themen:

Antiviral activity
Drug repurposing
Drug resistance
Drug-delivery
Journal Article
Microemulsion
Nanoemulsion
Review
Vaccine delivery

Anmerkungen:

Date Revised 21.12.2022

published: Print-Electronic

Citation Status PubMed-not-MEDLINE

doi:

10.1016/j.cocis.2021.101458

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM323703747